Maximizing Recruitment in ACST-2. Recruitment to Date Clinical trials require VERY large numbers of...
-
Upload
miles-parsons -
Category
Documents
-
view
215 -
download
3
Transcript of Maximizing Recruitment in ACST-2. Recruitment to Date Clinical trials require VERY large numbers of...
![Page 1: Maximizing Recruitment in ACST-2. Recruitment to Date Clinical trials require VERY large numbers of patients, because they study MODERATE effects… … therefore.](https://reader036.fdocuments.in/reader036/viewer/2022072006/56649d145503460f949e92ef/html5/thumbnails/1.jpg)
Maximizing Recruitment in ACST-2
![Page 2: Maximizing Recruitment in ACST-2. Recruitment to Date Clinical trials require VERY large numbers of patients, because they study MODERATE effects… … therefore.](https://reader036.fdocuments.in/reader036/viewer/2022072006/56649d145503460f949e92ef/html5/thumbnails/2.jpg)
Recruitment to Date
Clinical trials require VERY large numbers of patients,
because they study MODERATE effects…
…therefore we need to recruit as many
patients as we can!Visit the website for daily recruitment rate:
www.acst-2.org
ACST-2recruitment
to date:
1,709
![Page 3: Maximizing Recruitment in ACST-2. Recruitment to Date Clinical trials require VERY large numbers of patients, because they study MODERATE effects… … therefore.](https://reader036.fdocuments.in/reader036/viewer/2022072006/56649d145503460f949e92ef/html5/thumbnails/3.jpg)
Clinician
Duplex Doppler
CTAMRA
Patient consent and entering in trial
DETECTION
Patient eligibility discussed (e.g. MDT)
TIA/stroke clinics
Stroke inpatients
Vascular outpatients
Screening
Cardiology or cardiothoracic surgery assessment
WHERE WE FIND TRIAL PATIENTSWHERE WE FIND TRIAL PATIENTS
![Page 4: Maximizing Recruitment in ACST-2. Recruitment to Date Clinical trials require VERY large numbers of patients, because they study MODERATE effects… … therefore.](https://reader036.fdocuments.in/reader036/viewer/2022072006/56649d145503460f949e92ef/html5/thumbnails/4.jpg)
Know the Inclusion Criteria• Tight carotid artery stenosis (>70%), confirmed by duplex ultrasound
• MRA, CTA or Angiogram shows that CEA and CAS are both practicable
• No symptoms or signs* on the IPSILATERAL side for at least 6 months
• Doctor & Patient are uncertain about whether to treat with CEA or CAS
• Patient is fit, willing for follow- up and is likely to live 5 years
• Patient is still eligible even if they’ve had a symptom or sign* on the CONTRALATERAL side
(*MR/CT infarcts)
![Page 5: Maximizing Recruitment in ACST-2. Recruitment to Date Clinical trials require VERY large numbers of patients, because they study MODERATE effects… … therefore.](https://reader036.fdocuments.in/reader036/viewer/2022072006/56649d145503460f949e92ef/html5/thumbnails/5.jpg)
Patient Enrolment
• Asymptomatic patients should be given the trial information leaflet at their FIRST appointment
• Confirm patients are willing to accept randomisation allocation and obtain the consent form immediately
• Patients should be able to talk to the same doctor/ research nurse each time about the trial - give patients a card with your contact details and the trial
name.
![Page 6: Maximizing Recruitment in ACST-2. Recruitment to Date Clinical trials require VERY large numbers of patients, because they study MODERATE effects… … therefore.](https://reader036.fdocuments.in/reader036/viewer/2022072006/56649d145503460f949e92ef/html5/thumbnails/6.jpg)
Patient- centric Approach:
• Ensure an impartial explanation of BOTH procedures in the trial: CEA and CAS
• Be aware of using sensitive words like:– ‘randomization’ vs 50:50 chance– ‘uncertainty’ vs equal likelihood– ‘clinical trial’ vs clinical study
![Page 7: Maximizing Recruitment in ACST-2. Recruitment to Date Clinical trials require VERY large numbers of patients, because they study MODERATE effects… … therefore.](https://reader036.fdocuments.in/reader036/viewer/2022072006/56649d145503460f949e92ef/html5/thumbnails/7.jpg)
Think TEAM:
Together Everyone Achieves More
• Encourage Team Work across all disciplines• Include nurses and junior doctors in your team
and encourage them to take part in the trial • Enrol a Research Nurse or Trial Co-ordinator
to help run the trial at your site• Arrange meetings with interested parties and
inform them about the trial (e.g. at your MDT)
![Page 8: Maximizing Recruitment in ACST-2. Recruitment to Date Clinical trials require VERY large numbers of patients, because they study MODERATE effects… … therefore.](https://reader036.fdocuments.in/reader036/viewer/2022072006/56649d145503460f949e92ef/html5/thumbnails/8.jpg)
Regular Annual follow up
• Assess patients with previous ‘stroke-like’ symptoms who have a suitable stenosis on an
annual basis
If you follow-up patients with >60% stenosis annually, review records to flag potential
patients.
![Page 9: Maximizing Recruitment in ACST-2. Recruitment to Date Clinical trials require VERY large numbers of patients, because they study MODERATE effects… … therefore.](https://reader036.fdocuments.in/reader036/viewer/2022072006/56649d145503460f949e92ef/html5/thumbnails/9.jpg)
Useful documents• Patient Pathway• Inclusion Criteria• Recruitment Tips• Presenting to Patients
![Page 10: Maximizing Recruitment in ACST-2. Recruitment to Date Clinical trials require VERY large numbers of patients, because they study MODERATE effects… … therefore.](https://reader036.fdocuments.in/reader036/viewer/2022072006/56649d145503460f949e92ef/html5/thumbnails/10.jpg)
ACST-2 is here to help you!
“ Please do not hesitate to contact me should you have any questions – we are here to assist you!”
www.acst-2.orgEmail: [email protected]
Telephone: +44 (0) 1865 223074